Stakeholders also shared their views on how regulatory regimes for gene editing in other jurisdictions might affect, or are already affecting, their sectors, including potential operational and reputational impacts arising from differences in approach. Ministers are taking into account this evidence from stakeholders, alongside developments in the EU, as th...